Prevalence of Bovine Viral Diarrhoea Virus (BVDV), Bovine Herpes Virus 1 (BHV 1), Leptospirosis and Neosporosis, and associated risk factors in 161 Irish beef herds by Barrett, Damien et al.
RESEARCH Open Access
Prevalence of Bovine Viral Diarrhoea Virus
(BVDV), Bovine Herpes Virus 1 (BHV 1),
Leptospirosis and Neosporosis, and
associated risk factors in 161 Irish beef
herds
Damien Barrett1* , Mervyn Parr4, John Fagan2, Alan Johnson3, Jamie Tratalos6, Francis Lively7, Michael Diskin5
and David Kenny4
Abstract
Background: There are limited data available, in Ireland or elsewhere, to determine the extent of exposure to
various endemic diseases among beef cows and factors associated with exposure to causative pathogens. The
objectives of this study were to determine the herd and within herd prevalence of Bovine Viral Diarrhoea Virus
(BVDV), Bovine Herpes Virus 1 (BHV-1), Leptospirosis and Neosporosis in a large scale study of commercial beef
herds on the island of Ireland, and to examine herd level factors associated with exposure to these pathogens in
these herds.
Results: The average number of cows tested per herd was 35.5 (median 30). Herd level seroprevalence to Bovine
Herpesvirus-1(BHV-1), Bovine Viral-Diarrhoea Virus (BVDV), Leptospirosis and Neosporosis was 90%, 100%, 91% and
67%, respectively, while the mean within herd prevalence for the these pathogens was 40%, 77.7%, 65.7% and 5.7%,
respectively. The study confirms that the level of seroconversion for the four pathogens of interest increases with
herd size. There was also evidence that exposure to one pathogen may increase the risk of exposure to another
pathogen.
Conclusions: Herd level seroprevalences were in excess of 90% for BVDV, BHV-1 and Leptosporosis. Larger herds
were subject to increased exposure to disease pathogens. This study suggests that exposure to several pathogens
may be associated with the further exposure to other pathogens.
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Background
In recent years, the issue of herd health and, in particu-
lar, infectious disease has received increasing promin-
ence as a potential factor influencing reproductive
efficiency in Ireland and elsewhere. However, despite its
obvious critical importance, there are limited published
data available, to quantify the influence of various
endemic diseases on beef cow and herd fertility.
Reproductive performance in beef cow herds is related
to several management, physiological and disease factors
[1, 2]. The current level of reproductive performance in
Irish beef cow herds leave considerable room for im-
provement in achieving more efficient, sustainable and
profitable beef cow beef production [3]. There is a need
to establish the prevalences of the most significant infec-
tious diseases associated with impaired reproductive
performance.
Numerous bacterial, viral and protozoan pathogens
have been associated with infertility and abortion in cat-
tle. BVDV, BHV-1, Leptospira interrogans hardjo-bovis
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and Neospora caninum are four of the most significant
pathogens associated with infertility and abortion in
Irish cattle. While non-infectious agents probably con-
tribute more to overall reproductive wastage in cattle,
there is limited information on the extent and import-
ance of infectious disease on reproductive performance
in Irish beef cow herds.
BVDV is a pestivirus which is endemic in the cattle
population of several countries and is responsible for a
wide range of clinical syndromes, amongst which are im-
munosuppression and early embryonic death [4]. In re-
cent years, several countries including the Republic of
Ireland and Northern Ireland have initiated national
BVD eradication schemes. Data from the national BVD
eradication scheme in the Republic of Ireland (initiated
in 2012) reveal the presence of one or more BVD virus
positive animals is 8.74%, 5.96% and 3.311%, 2.38% of
beef herds for the years 2013, 2014, 2015 and 2016, re-
spectively (Graham, personal communication). A recent
study showed BVDV seroprevalence of 98% in Irish beef
cow beef herds [5]. Furthermore, in a study commis-
sioned by Animal Health Ireland prior to the launch of a
national BVD eradication scheme, BVDV was estimated
to cost the Irish beef cow industry between €32 and €41
per cow per year [6].
Bovine herpes virus 1 (BHV-1) is associated with clin-
ical syndromes such as rhinotracheitis, pustular vulvo-
vaginitis and balanoposthitis, abortion, infertility,
conjunctivitis and encephalitis in cattle [7, 8]. It estab-
lishes latent lifelong infection and becomes reactivated
during periods of immunosuppression, induced by
stressful incidents, resulting in virus excretion when in-
fection becomes re activated [9]. Two recent studies
conducted on Irish beef [10, 11] and dairy herds [11]
both reported herd level seroprevalence of BHV-1 to be
approximately 75% and that this was consistent through-
out the country.
Leptospirosis is a bacterial disease of cattle that is
characterised by reproductive failure in the form of abor-
tions, stillbirths and birth of weak calves. It is also a
zoonotic disease. In cattle, the leptospires of most inter-
est are interrogans hardjo-bovis and -prajitno genotypes
(i.e. sub-serovars). A number of studies have reported
reduced conception rates in seropositive dairy cows [12,
13].A previous study of Irish beef cow herds has shown
that 82% of herds were seropositive for leptospirosis,
with 40% of cows within those herds seropositive for
leptospirosis [14].
Abortions due to Neospora caninum typically occur
during the early second trimester, but may occur
throughout gestation. A number of authors have sug-
gested that cattle infected with the parasite are two to
12 times more likely to abort compared with uninfected
cattle [15, 16]. These can be sporadic, endemic or
epidemic-abortions [17]. In a large scale Canadian study,
cows seropositive for Neosporosis were 1.43 times more
likely to be culled for reproductive inefficiency than
seronegative cows [18]. A recent Australian study of
Neosporosis in beef cow herds reported that calving
rates were 10.4% lower in herds that had one or more
animals positive for Neosporosis [19] As far as the au-
thors of this paper are aware, this is the first serological
survey for Neosporosis in Irish beef cow herds.
The objectives of this study were to (i) determine the
herd and within herd prevalence of BVDV, BHV-1,
Leptospirosis and Neosporosis in a large cohort of com-
mercial beef herds on the island of Ireland, and (ii)
examine herd level factors associated with exposure to
these pathogens in these herds.
Methods
Herd selection and sampling method
In all, 6049 cows in 161 beef cow herds from across the
island of Ireland were sampled in this study. Of these,
156 were commercial beef cow herds, including 25 par-
ticipating in national extension programmes. The
remaining five herds were located on state owned re-
search facilities. Blood sampling took place once for each
herd over the summer months of either 2014 or 2015,
and only spring calving cows within the herds were sam-
pled. Data on herd vaccination and mineral supplemen-
tation policies were gathered at the time of sampling.
Ethical statement on blood sampling
All experimental procedures involving animals were
licensed by the Irish Health Products Regulatory
Authority (HPRA). Protocols were conducted in accord-
ance with the Cruelty to Animals Act (Ireland 1876, as
amended by European Communities regulations 2002
and 2005) and the European Community Directive 86/
609/EC and were sanctioned by the Teagasc Animal
Ethics Committee. Blood samples were collected via the
coccygeal vessel into 10 ml non additive containers
(Becton Dickenson Vacutainer Systems, Plymouth, UK)
for serological analysis.
Laboratory processing
Sera were centrifuged and aliquots for each test were
partitioned into serum vials and frozen at −20 °C pend-
ing analysis. Sera were screened using commercially
available ELISA kits for BVDV, BHV-1, Leptospirosis
and Neosporosis in Department of Agriculture, Food
and the Marine Regional Veterinary Laboratory service
(RVL). In each case the tests were carried out according
to the manufacturer’s instructions.
For herds where IBR vaccination was reported, the kit
used for BHV-1 was the IDEXX IBR gE kit (IDEXX,
Maine, USA). The manufacturer’s report a sensitivity of
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98.41% and a specificity of 99.76%. The cut off for a
positive sample was an SN (sample to negative control
ratio) value of <0.6.
In herds that did not declare an IBR vaccination policy
the testing kit used for BHV-1 was the IDEXX IBR gB X3
(IDEXX, Maine, USA). The cut off for a positive sample
for this kit was >55% blocking. The manufacturer’s report
a sensitivity of 100% and a specificity of 99.8%.
The kit used for BVDV antibody was the Svanovir
BVD – Ab Bovine Virus Diarrhoea Virus antibody Test
(Boehringer Ingelheim Svanova, Uppsala, Sweden). The
cut off for a positive result was a PP (percent positivity)
value >35. The manufacturer’s report a sensitivity of
100% and a specificity of 98.2%.
The kit used for Leptospirosis antibody was the
PrioCHECK L.hardjo antibody kit (Thermofischer,
Massachusetts, USA). The manufacturer’s report a sensitiv-
ity of 99% and a specificity of 85%. The cut off for a posi-
tive sample was a PP (percent positivity) value of >45%.
The kit used for Neosporosis antibody was the IDEXX
Neospora antibody kit (IDEXX, Maine, USA). The man-
ufacturer’s report a sensitivity of 97.56% and a specificity
of 98.53%. The cut off for a positive sample was a S/P
(sample to positive ratio) value of >0.4.
Herd level BVDV status
The herd level BVDV status for each of the Republic of
Ireland herds (n = 139) was accessed from the Irish
Cattle Breeding Federation (ICBF) database for the years
2013, 2014 and 2015. This information was not available
for the herds located in Northern Ireland.
Data management and analysis
Data were collated on Microsoft Excel spreadsheets
(Microsoft Corporation, Redmond, WA, USA). Details
of the herd demographics for Republic of Ireland herds
are presented in Table 1. Only serological data and vac-
cination history were available for Northern Ireland
herds. Each farmer was asked to complete a short ques-
tionnaire on vaccination and mineral supplementation
practices in their herd. The vaccination status of the
herd was based on the recall of the owner when com-
pleting the questionnaire at the time of sampling. We
therefore cannot be certain that vaccinations were car-
ried out in full compliance with the manufacturers’
instructions. However, where the farmer reported using
a BVDV or Leptospirosis vaccine, these herds were re-
moved from the analysis, in order to ensure, in as much
as possible, that the analysis only related to naturally oc-
curring infections. In the case of IBR / BHV-1, only
marker vaccines have been available in the Republic of
Ireland since 2005, and herds using IBR vaccination
were tested with the marker vaccine test kit. Both
marker and conventional vaccines are available for pur-
chase in Northern Ireland and this may account for
some of the seroconversion seen in the NI herds, as the
tests we had available could not differentiate between
seroconversion due to natural infection and seroconver-
sion due to the use of a non-marker vaccine.
Herd level registration and movement data were ob-
tained from the Irish Department of Agriculture, Food
and the Marine’s Animal Identification and Movement
(AIM) database and the following variables were calcu-
lated for each herd: herd size, number of cows, overall
mortality rate, calf mortality up to 30 days of age, calves
per cow per year and purchase rate. These variables and
herd level prevalence of the various serological tests were
calculated and entered into the spreadsheet, in addition to
herd vaccination history. Statistical analysis was carried
out using Stata 14 (StataCorp LP, Texas, USA). A descrip-
tive statistical analysis of the data was initially conducted.
In order to examine the potential for regional differences
the herds were divided into seven geographical regions
(Fig. 1) as described by Ryan et al. [14].
Relationship between pathogen and within herd
seroprevalence
A univariate linear regression analysis was initially car-
ried out using a range of herd level statistics downloaded
from the AIM system and with the herd prevalence of
Table 1 Mean and median total herd size, number of cows, overall mortality rate, calf mortality rate up to 30 days, the number of
calves per cow per year and purchase rate among Republic of Ireland herds in the study
Region Herd Size No cows Mortality Rate Calf Mortality rate up to 30 days Calves per cow per year Purchase rate
Mean Median Mean Median Mean Median Mean Median Mean Median Mean Median
1 88 79 46.9 41.5 5.3 5.4 2.8 2 0.98 1 16.2 16.6
2 78 67 33.9 32.5 4.2 3.1 2.2 2 0.87 0.97 17.5 13.8
3 190 134 74.5 54 4.5 3.6 4.9 4.23 0.85 0.99 15.8 15.6
4 131 116 42.7 43 3.4 2.1 4.1 3.3 0.93 1 26.7 13.5
5 158 136 58.4 49 3.6 3.3 4.6 3.6 0.95 1 20.5 16.3
6 172 135 57.4 53.5 3 2.9 3.4 2.9 0.86 1 15.9 13.1
Overall 145 114 53.8 46 3.7 3.2 3.7 2.7 0.9 1 18.6 13.85
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each pathogen as the dependent variable of interest.
Variables with a P value less than 0.2 were then consid-
ered for inclusion in a multivariate linear regression
model for each pathogen (Tables 4, 6 and 9 and 11).
Variables with a P value >0.05 were removed from the
model in a stepwise fashion, until the variables
remaining in the final model all reached a P value <0.05.
For Leptospirosis and BVDV data from only non-
vaccinating herds were included in the statistical model.
Logistic regression for BVD eradication scheme herd status
In order to identify independent variables for inclusion in
a multivariate model for BVDV, univariate logistic
regressions was calculated. The dependent variable was
the disclosure of BVDV positive calves in the course of
the national BVDV eradication scheme, from the incep-
tion of the scheme until 2015. Variables with a P value less
than 0.2 were considered for inclusion in the multivariate
model. Variables with a P value >0.05 were removed from
the model in a stepwise fashion, until the variables
remaining in the final model had a P value <0.05, as out-
lined for the linear regression analysis above.
Results
There were 14, 18, 16, 17, 48, 26 and 22 herds in
Regions 1 to 7 respectively. The mean total herd size
Fig. 1 Geographical spread of the regions employed in the study
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was 145.0, which varied from 82.4 (median 70.0) in
Region 1 to 172.0 (median 135.0) in Region 4 (Table 1).
The mean number of calves born per herd (which was a
proxy for the number of breeding cows in the herd) was
53.8 overall (median 46), and similar to the herd size
varied from 33.9 (median 36.0) (Region 1) up to 58.4
(median 49.0) (Region 3). The average number of cows
tested per herd was 35.5 (median 30). The mean level of
overall herd mortality was 3.7% (median 3.2%), ranging
from 4.7% (median 3.8%) % in Region 1 to 3.0% (median
2.9%) in region 4. Although the mean level of calf mor-
tality up to 30 days of age was also 3.7% (median 2.7%),
this ranged from 2.4% (median 2%) in region 1, to 4.6%
(median 3.6%) in region 3. The overall mean rate of pur-
chases into the herds was 18.6, (median 13.85), and this
varied from 15.9 (median 13.1) (region 4) to 21.4
(median 16.6) (region 1) (Table 1). There were no clear
geographic patterns observed between regions and be-
tween herds.
Seroprevalence data
For BHV-1, the herd seroprevalence was 90% overall
(Table 2, and this ranged from 76% in region 3 to 100%
in Region 7. The mean within herd seroprevalence for
BHV-1was 39.8%, and ranged from 11.1% in the Region
2 up to 45.5% in Region 7. Overall, 18% of herds were
vaccinating for IBR, and this ranged from 11.5% in the
Republic of Ireland to 45.5% in Northern Ireland. Results
from the multivariate regression model indicated a posi-
tive association between BHV-1 seroprevalence and the
herd prevalence of Neosporosis, the disclosure of BVDV
positive animals within the BVD eradication scheme,
herd size, and mortality rate (all age groups) (Table 3).
There was a negative association between BHV-1 sero-
prevalence and calf mortality up to 30 days of age as well
as with overall herd mortality.
For BVDV, the herd seroprevalence was 100% in all re-
gions (Table 4). The mean within herd seroprevalence of
BVDV was 77.7%, and ranged from 42.8% in Region 2
up to 88.3% in Region 7. Overall, 32.3% of herds were
vaccinating for BVDV, and this ranged from 23.5% in re-
gions 4 and 5 to 57.1% in Region 1. The linear regression
model for BVDV seroprevalence, showed associations
with the seroprevalence of Neosporosis, the overall
number of cattle that died in the herd in 2014, and the
calves produced per cow in 2014 (Table 5).
One or more BVDV virus positive animals were found
in 46 of the 139 (34%) Republic of Ireland herds since
the inception of the compulsory BVD programme in the
Table 2 Herd sero prevalence and the percentage of herds
vaccinating for BHV-1, the mean and median number of cows
tested per herd, and the mean and median within herd BHV-1
sero prevalence
Region % BHV-1
vaccination
BHV 1 Herd
sero prevalence
BHV-1Within
Herd Prevalence
Mean Median
1 0 90 49.2 54.8
2 11.1 83 18.6 10.6
3 12.5 94 48.2 46.3
4 11.8 76 30.6 26.9
5 8.8 94 44.1 48.2
6 25.0 96 36.1 33.1
7 45.5 100 52.3 44.5
Overall 18.0 90 39.79 38.1
Table 3 A linear regression model of BHV-1sero prevalence with
Neospora within herd prevalence, the disclosure of BVD virus
positive animals in the herd, herd size, the number of animals dead
per year, mortality rate, mortality rate up to 30 days as predictors
which fit
Coef. Std.
Err.
t P > t 95% Conf.
interval
Neospora within herd
sero prevalence
0.852 0.369 2.11 0.022 0.123 1.562
Disclosure of BVD virus
positive animals in herd
11.466 5.249 2.18 0.031 1.083 21.851
Herd Size 0.139 0.049 2.84 0.05 0.042 0.236
Overall mortality −2.416 0.977 −2.47 0.015 −4.350 −0.483
Mortality rate 3.716 1.325 2.80 0.006 1.095 6.337
Mortality rate up to
30 days of age
−0.186 0.076 −2.45 0.015 −0.337 −0.036
Intercept 15.654 6.649 2.35 0.020 2.501 28.807
Number of observations =139
F (6,132) = 4.3
Prob >F = 0.0005
R-square = 0.1636
Adj R- squared = 0.1256
Root MSE = 27.85
Table 4 The herd sero prevalence for BVDV, the mean and median
within herd BVDV sero prevalence, percentage of herds vaccinating
for BVD, and the percentage of herds where a BVDV animal was
disclosed
Region BVDV Herd Sero
prevalence
BVDV Within
Herd Sero
prevalence
% BVD
vaccination
% herds with
BVD virus
positive calves
Mean Median
1 100 71.7 68 57.1 50
2 100 42.8 37.7 38.9 28
3 100 87.8 93.7 25.0 50
4 100 81 98.1 23.5 18
5 100 69.3 72.9 23.5 23
6 100 80.5 88.4 32.5 35
7 100 88.3 96 36.4 NA
Overall 100 77.7 85.2 32.3 34
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Republic of Ireland (Table 4). The annual incidence of
herds where BVDV positive animals were founded for
2013, 2014 and 2015 were 12.2%, 7.9% and 9.3%. The
disclosure of BVD virus positive animals was associated
with increasing herd size and increasing BHV-
1seroprevalence (Table 6).
For Leptospirosis, the overall herd seroprevalence was
91%, and this ranged from 80% in Region 1 to 100% in
Region 7 (Table 7). The mean within herd seropreva-
lence of leptospirosis was 65.7%, and ranged from 43.4%
in Region 4 up to 73.3% in Region 6. Overall, 47.2% of
herds were vaccinating for Leptospirosis, and this ranged
from 23.5% in Regions 4 to 78.6% in Region 1. There
was an association between the use of BVDV vaccine in
the herd, the herd size and the purchasing patterns, par-
ticularly in 2014 and the Leptospirosis seroprevalence in
the Leptospirosis linear regression model (Table 8).
For Neosporosis, the herd prevalence was 67% overall,
and this ranged from 44% in Region 2 to 85% in Region
6 (Table 9). The mean within herd seroprevalence of
Neosporosis was 5.7%, and ranged from 2.2% in Region
2 up to 7.4% in Region 1. Linear regression revealed a
negative association between Neosporosis and both (i)
the disclosure of BVDV positive animals in the herd
during the BVDV eradication scheme and (ii) herd
BHV-1seroprevalence (Table 10).
Discussion
This study describes the herd level characteristics of a
large scale study of over 6000 beef cows from 161 herds
and is the first study of its kind to be conducted across
the island of Ireland. The serological sampling and ana-
lysis for the four pathogens of interest was carried out
specifically for the purposes of the study. To the know-
ledge of the authors, no previous study has concurrently
examined multiple pathogens in the same beef cows,
which facilitates the study of potential associations
amongst these pathogens on economically important
outcomes at herd level. As part of our study we com-
bined seroprevalence data, a targeted brief herd ques-
tionnaire, data on the BVDV status of each herd from
the ICBF database, and animal identification and move-
ment data (AIM data) for the first time within an Irish
context. This is one of the first studies in Europe to inte-
grate data from the national cattle identification and
movement database with disease prevalence data, to
Table 5 A linear regression model of BVDV sero prevalence
with Neospora canium within herd prevalence, the number of
animals dead per year, and calves per cow per year as
predictors which fit
Coef. Std.
Err.
t P > t 95% Conf.
interval
Neospora within
herd sero prevalence
0.807 0.402 2.01 0.048 0.008 1.606
Overall mortality 1.550 0.561 2.76 0.007 0.435 2.665
Calves per
cow per year
−30.431 13.401 −2.27 0.026 −57.059 −3.804
Intercept 93.377 12.341 7.57 0.000 68.856 117.898
Number of observations =93
F (3,89) = 4.50
Prob >F = 0.0055
R-square = 0.1317
Adj R- squared = 0.1025
Root MSE = 23.47
Table 6 The presence of BVD virus positive animals in the herd
logistic regression model
Odds ratio Std. Err. z P > z 95% Conf.
interval
No cows in herd 1.025 0.010 2.62 0.009 1.006 1.045
BHV-1herd sero
prevalence
1.013 0.006 2.02 0.044 1.000 1.026
Intercept 0.118 0.056 −4.51 0.000 0.046 0.298
No of observations =139
LR chi 2 (2) = 12.98
Prob > chi 2 = 0.0015
Pseudo R 2 = 0.0735
Log likelihood = −81.755
Table 7 Herd seroprevalence and within herd sero prevalence
and percentage of herds vaccinating for Leptospirosis
Region Herd Sero
Prevalence
Within Herd
Sero Prevalence
% Leptosporisis
vaccination
Mean Median
1 80 79.2 77.7 78.6
2 83 70.4 81.4 50.0
3 94 68.2 68.8 31.3
4 88 43.4 45.9 23.5
5 94 72.6 83.3 52.9
6 96 73.3 78.6 45.0
7 100 60.7 72.2 50.0
Overall 91 65.7 75.4 47.2
Table 8 A linear regression model of leptosporosis sero prevalence
with number of cattle purchased in marts and herd size as
predictors which fit
Coef. Std. Err. t P > t 95% Conf. interval
Herd vaccinating
BVD
27.979 12.373 2.26 0.027 3.293 52.664
No of mart
purchases in 2014
0.247 0.081 3.03 0.003 0.084 0.041
Herd size 0.093 0.029 3.21 0.002 0.035 0.151
Intercept 44.929 5.013 8.96 0.000 34.928 54.93
Number of observations =73
F (3,69) = 9.92
Prob >F = 0.000
R-squared = 0.3013
Adj R- squared = 0.2709
Root MSE = 23.942
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identify risk factors associated with the occurrence of
BHV-1, BVDV, Leptospirosis and Neosporosis.
Increasing herd size emerged as a factor associated
with seroconversion to BHV-1, BVDV and Leptospirosis,
and the disclosure of BVDV positive animals. Herd size
has previously been documented as a significant risk
factor associated with exposure to these pathogens in
Ireland [5, 11, 14, 20]. Similar experiences have been
documented internationally for several pathogens.
Increasing herd size increases the probability of an indi-
vidual animal becoming exposed to pathogens and be-
coming a carrier animal, and is a well recognised risk
factor for the occurrence of disease. Larger herds are
likely to have management practices which could predis-
pose them to exposure to the pathogens. Additionally
the purchase of animals into the herd is often required
to achieve increased herd size but this too is an
acknowledged risk factor associated with exposure to
pathogens.
There were numerous associations identified between
the pathogens under investigation. For example, the
seroprevalence of BHV-1was associated with the sero-
prevalence of Neosporosis, and the disclosure of BVDV
positive calves in the herd. Indeed, the role of co-infec-
tion has been previously described by Van Leeuwen et
al. [15], where cows seropositive for Bovine Leukaemia
Virus (BLV) were 1.5 times more likely to be seroposi-
tive for Neosporosis than BLV seronegative cows. An-
other possible explanation is that infection with one of
the pathogens could facilitate infection with another.
The role of BVDV, in particular, as an immunosuppres-
sive agent is well documented [4].
BHV-1
In addition to herd size and associations with other
pathogens increased BHV-1 seroprevalence was associ-
ated with increased overall herd mortality rates. Previous
studies have reported herd level seroprevalences of 77%
and 74% in Northern Ireland and the Republic of
Ireland, respectively [5, 20]. The 90% BHV-1 herd preva-
lence reported in the present study would indicate that
BHV-1 is endemic in the Irish cattle population. The
level of herd prevalence described here is probably re-
lated to the relatively large size of the participating
herds. An earlier study also found a significant associ-
ation between BHV-1 seroprevalence and herd size in
Ireland [11]. Previous studies have reported IBR vaccine
usage of 1.8% and 11% in the Republic of Ireland and
Northern Ireland respectively [11, 20]. The comparable
levels of IBR vaccination in the present study, were
11.5% and 45.5% respectively, which is a marked in-
crease on the previous studies by Cowley et al., [11, 20].
This may reflect a greater awareness of animal health is-
sues among the owners of our study herds employed
here, which included research herds and herds
participating in Knowledge Transfer demonstration
programmes.
BVDV seroprevalence
Previous studies have described herd level seroconver-
sion to BVDV in excess of 98% in both the Republic of
Ireland and Northern Ireland [5, 20]. Similar levels of
herd seroconversion to BVDV have been reported in
England and Wales [21]. In our study 32% of herds were
vaccinated for BVD, which is substantially greater than
the rates of 2.2% in the Republic of Ireland and 16% in
Northern Ireland reported in studies of beef herds [5,
20]. We found evidence of an association between sero-
prevalence of both BVDV and Neosporosis. BVDV
seroprevalence was also positively associated with the
total herd mortality (2014) in the herd. There was a
negative association between the calves produced per
cow per year (2014) and increased BVDV seroprevalence
in the herd. Both of these findings are not unexpected as
BVDV infection is associated with increased calf mor-
bidity, increased mortality as well as early embryonic
Table 9 Herd and within herd seroprevalences for Neospora
canium
Region Neospora herd sero prevalence Within Herd Prevalence
Mean Median
1 60 7.4 6.6
2 44 2.2 0
3 75 4.5 2.05
4 76 6.2 3.3
5 71 6 3.9
6 85 5.9 5
7 55 6.9 2.45
Overall 67 5.7 3.7
Table 10 A linear regression model of Neospora caninum sero
prevalence with BHV-1sero prevalence and the disclosure of
BVD virus positive calves as predictors which fit
Coef. Std. Err. t P > t 95% Conf.
interval
BHV-1Herd sero
prevalence
0.045 0.018 2.45 0.016 0.008 0.082
Disclosure of
BVD virus positive
animals in herd
−2.355 1.171 −2.01 0.046 −4.671 −0.040
Intercept 4.531 0.907 5.00 0.000 2.739 6.325
Number of observations =139
F (2,136) = 4.18
Prob >F = 0.0173
R-squared = 0.0579
Adj R- squared = 0.044
Root MSE = 6.357
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death [22], which would decrease the number of calves
per cow per year.
Disclosure of BVD virus positive calves
The disclosure of BVDVpositive calves was related to
the seroprevalence of BHV-1and herd size. One third of
the Republic of Ireland study herds participating in the
national BVD eradication scheme reported one or more
BVD virus positive calves in the initial 3 years of the
scheme [23]. The disclosure of BVDV positive calves in
many of the herds in this study could account for the
high levels of herd and within herd seroconversion ob-
served. Herd size was a significant risk factor in this
study which is consistent with previous Irish reports
[24]. It is of note that the disclosure of BVDV positive
calves in the herds in this study was consistently higher
than herds in the general population as recorded as part
of the Irish national BVD eradication scheme [23].
Leptospirosis seroprevalence
In addition to herd size, the seroprevalence of Leptospirosis
was associated with the level of livestock mart pur-
chases in 2014. It is difficult to determine the signifi-
cance of this, as it was only found to reach statistical
significance in 2014. This association is likely to be bio-
security related, and was associated with movement of
animals between holdings and spread within holdings.
In this study there was evidence of seroconversion
among 90% of non-vaccinating herds, which was greater
than the 82% herd level seroprevalence described in a
previous Irish study of beef cow herds [14] (Table 7).
The mean within herd seroprevalence was 75%, which
was almost twice the rate of the 40% seroprevalence de-
scribed by Ryan et al., [14]. That study concluded it was
likely that there were carrier animals actively transmit-
ting leptospires at the seroprevalences described in their
study. They also described a regional effect in relation to
Leptospirosis seroprevalence, although no such pattern
was observed in our study. They also reported a positive
association between herd seroprevalence and herd size.
Previously, Leptospirosis was described as independent
of region and rainfall [25]. A previous UK study has de-
scribed a 24.2% seroprevalence in beef herds [26]. The
high within herd seroprevalence in our study is probably
related to the fact that beef calves spend relatively more
time in contact with adult cows than do dairy calves and
there is consequently a greater risk of exposure to
carrier animals in the herd. In addition, this contact is
greater during winter housing, where calves tend to be
kept on creep areas and are able to enter a pen of calved
cows, some of which may be carriers. In this study,
almost half of herds (47%) were vaccinating for
Leptospirosis, which is substantially greater than the 3%
described by Ryan et al., [14].
Neospora seroprevalence
The herd seroprevalence for Neosporosis of 67% re-
ported here is almost identical to that of a similar study
in Australian beef cow herds [19], which also reported a
within herd seroprevalence similar to our findings. The
within-herd prevalence of Neosporosis was relatively low
compared to the other three pathogens studied, which
probably reflects the fact that transmission of Neosporosis,
is, for the most part vertical [27]. A previous US study
found prevalence was lower among beef cows grazed
on pasture as opposed to housed cows [28]. This might
suggest that horizontal transmission, or exposure from
a point source, could account for herds with a higher
within herd seroprevalence. Exposure to Neospora cani-
num has previously been associated with the presence
of dogs and wild canine species such as foxes on the
farm [15, 16]. In our study, participants were not asked
about the presence of dogs on the farm, but it is worthy
of further consideration. The seroprevalence of Neos-
porosis was associated with the seroprevalence of BHV-
1and the disclosure of BVDV positive animals in the
herd. Seroconversion to Neosporosis has also
previously been linked to the presence of BVDV expos-
ure in herds [15].
The farmers that participated in our study volunteered
to do so and were not evenly distributed across the is-
land of Ireland. Region did not emerge as a significant
variable in any of the multivariate analyses and the dis-
ease prevalences in the various regions were broadly
similar. While this study may not be representative of
beef cow herds overall, participating herds came from a
wide range of sizes, which enabled us to adequately in-
vestigate the effect of herd size.
While there are few perfect serological tests available,
the tests that were used in this study were of a high sen-
sitivity and specificity. We are confident that the tests
BHV-1, BVDV and Letporosis provided areflection of
the sero status of the animals tested. However, given the
dynamics of the host parasite interaction and the charac-
teristics of neospora serological tests, it is probable that
the Neospora ELISA underestimated the true prevalence
of Neosporosis in the cows tested [29].
The level of seroconversion to BHV-1in Northern
Ireland may have been over estimated, as conventional non
marker BHV-1vaccines are still available on the market
there. For this reason, data from herds located in Northern
Ireland were not included in the linear model, and the
BHV 1seroprevelance in the various regions was calculated
individually as we avoided using a cumulative figure so as
to prevent any one region biasing the overall results.
Seroconversion is a reflection of historic exposure to a
particular pathogen, and is not necessarily an accurate
reflective of infection status of an individual animal.
However, a high herd seroprevalence, especially among
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younger animals in a herd, may be suggestive of active
infection in that herd. This study was herd based and
could not take account of the age of the animals within
those herds. The issue of individual animal factors will
be addressed in a parallel piece of research (Parr et al.,
unpublished). Only seropositive animals were included
in calculating the herd seroprevalence, and animals with
an inconclusive test result were treated as seronegative
as this was a herd level based study.
Vaccine usage was much higher among herds in this
study than in previous studies. This may be a reflection of
the targeted nature of participant selection, whereas previ-
ous studies selected herds randomly. The farmers in our
study volunteered for inclusion and were therefore likely
to be more motivated than the general population.
Conclusions
Our findings support those of several previous studies
that as herds increase in size there is increased exposure
to pathogens. Consequently farmers with larger herds
need to be aware that they must increase their efforts to
avoid the introduction and spread of pathogens to their
herds, to establish the health status of their herds and
determine what mitigation measures are required to
address those diseases.
This study has also shown that exposure to several
pathogens is associated with exposure to other patho-
gens. This suggests that there is a common factor
common to the exposure among these herds, which is
likely to be related to biosecurity. This also indicates that
biosecurity needs greater attention in larger herds.
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